Investment firms Intermediate Capital Group and Merieux Equity Partners have agreed to acquire Italian generics drugmaker Doc Generici from CVC Capital Partners for an undisclosed amount.
The pharmaceutical company may have been valued at about 1.1 billion euros ($1.2 billion), people familiar with the matter said previously. Bloomberg reported last week that ICG and CVC were close to a deal.
The takeover will be among the biggest announced for a European health-care company this year, according to data compiled by Bloomberg. While the global volume of deals in pharmaceuticals, biotechnology and health products and services is up about 14 percent ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.